« Previous
Next »
Heart, Lung and Circulation
Volume 18, Issue 2
, Pages 123-130
, April 2009
Quantitative and Temporal Differences in Coagulation, Fibrinolysis and Platelet Activation after On-Pump and Off-Pump Coronary Artery Bypass Surgery
References
- . Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery. J Thorac Cardiovasc Surg. 2005;130(2):303–308
- . About the activation of the coagulation system during on-pump and off-pump coronary surgery and the use of antifibrinolytic drugs. J Thorac Cardiovasc Surg. 2006;132(3):733–734(author reply 734)
- . Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress. Eur J Cardiothorac Surg. 2003;24(2):260–269
- . The influence of the duration of cardiopulmonary bypass on coagulation, fibrinolysis and platelet function. Thorac Cardiovasc Surg. 2001;49(3):153–156
- . Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate?. Ann Thorac Surg. 1999;67(5):1370–1375
- . Activation of coagulation and fibrinolysis during coronary surgery: on-pump versus off-pump techniques. Anesthesiology. 2001;95(5):1103–1109
- . The systemic inflammatory response syndrome and off-pump cardiac surgery. Heart Surg Forum. 2001;4(Suppl 1):S7–S13
- . Haemostatic changes in the pulmonary blood during cardiopulmonary bypass. Blood Coagul Fibrinol. 1996;7(5):567–577
- . Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation. 1996;93(11):2014–2018
- . Monitoring thrombin generation with prothrombin fragment 1, 2 assay during cardiopulmonary bypass surgery. Thromb Res. 1996;84(1):45–54
- . von Willebrand factor and urinary albumin excretion are possible indicators of endothelial dysfunction in cardiopulmonary bypass. Eur J Cardiothorac Surg. 1998;13(4):385–391
- . Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass. Lancet. 1994;344(8931):1192–1193
- . Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood. 1993;82(11):3350–3357
- . Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology. 2002;97(4):837–841
- . Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass. Thromb Haemost. 2000;84(1):124–128
- . Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg. 1997;113(3):576–584
- . Release of von Willebrand factor by cardiopulmonary bypass, but not by cardioplegia in open heart surgery. Thromb Res. 1994;73(1):21–29
- . The role of von Willebrand factor in haemostasis and blood loss during and after cardiopulmonary bypass surgery. Blood Coagul Fibrinol. 1995;6(7):650–658
- . Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1993;106(5):828–833
- . Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass. Arch Surg. 2001;136(8):909–916
- . Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg. 1998;65(3):712–718
- . Thrombin-antithrombin complexes and prothrombin fragment 1+2 in aorto-coronary bypass surgery: relation to graft occlusion. Hematol Pathol. 1994;8(1-2):35–42
- . Coagulation factors influencing thrombosis of aorta-coronary bypass grafts. J Thorac Cardiovasc Surg. 1977;73(2):309–311
- . Should standard on-pump protamine dosing formulas be recalculated for off-pump coronary artery bypass grafting?. Heart Surg Forum. 2004;7(1):42–44
- . Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery. J Anesth. 2007;21(3):297–303
- . Effects of intracoronary shunts on coronary endothelial coating in the human beating heart. Ann Thorac Surg. 2004;77(3):776–780
- . The increase of plasminogen activator inhibitor activity is associated with graft occlusion in patients undergoing aorto-coronary bypass surgery. Br J Haematol. 1997;99(2):262–267
- . Haemostatic function in patients undergoing coronary artery bypass grafting: peroperative perturbations and relations to saphenous vein graft closure. Thromb Res. 2000;98(1):39–49
- . Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass. Blood Coagul Fibrinol. 1994;5(5):679–685
- . Effect of cardiopulmonary bypass on the circulating level of soluble GMP-140. Ann Thorac Surg. 1994;58(2):478–482
- . Soluble adhesion molecules and myocardial injury during coronary artery bypass grafting. World J Surg. 2003;27(2):140–144
- . The role of tissue factor and P-selectin in the procoagulant response that occurs in the first month after on-pump and off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2005;130(6):1561–1566
- . Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2007;134(1):132–138
- . Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res. 1996;32(4):733–742
- . Soluble P-selectin and the postoperative course following cardiopulmonary bypass in children. Paediatr Anaesth. 2001;11(3):303–308
- . P-selectin monoclonal antibody may attenuate the whole body inflammatory response induced by cardiopulmonary bypass. Asaio J. 2000;46(3):334–337
PII: S1443-9506(08)00866-4
doi: 10.1016/j.hlc.2008.08.012
© 2008 Australasian Society of Cardiac and Thoracic Surgeons and the Cardiac Society of Australia and New Zealand. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Heart, Lung and Circulation
Volume 18, Issue 2
, Pages 123-130
, April 2009
